1.Kobasa, D, Takada, A, Shinya, K, et alEnhanced virulence of influenza A viruses with the haemaglutinin of the 1918 pandemic virus. Nature. 2004;431:703–707.
2.Hoft, DF, Belshe, RB.The genetic archaeology of influenza. N Engl J Med. 2004;351:2550–2551.
3.Tumpey, TM, Basler, CF, Aguilar, PV, et alCharacterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005;310:77–80.
4.Monto, AS.The threat of an avian influenza pandemic. N Engl J Med. 2005;352:323–325.
5.Scholtissek, C, Rohde, W, von Hoyningen, V, et alOn the origin of the human influenza subtypes H2N2 and H3N2. Virology. 1978;87:13–20.
6.Kawaoka, Y, Krauss, S, Webster, RG.Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol. 1989;63:4603–4608.
9.Kman, NE, Nelson, RN.Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. 2008;26:517–547.
12.Charrel, RN, Lamballerie, X, Raoult, D.Chikungunya outbreaks—the globalization of vectorbourne diseases. N Engl J Med. 2007;8:769–771.
13.Over 22,000 Chikungunya infections. Bangkok Post. May 29, 2009.
20.Briese, T, Janusz, PT, McMullan, LK, et alGenetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009;4:e1000455.
24.World Health Organization. Outbreaks of Rift Valley fever in Kenya, Somalia and United Republic of Tanzania, December 2006–April 2007. Wkly Epidemiol Rec. 2007;82:169–178.
26.West Nile virus activity–United States, 2007.MMWR Morb Mortal Wkly Rep. 2008;57:720–723.
28.Thompson, WW, Weintraub, E, Dhankhar, P, et alEstimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Virus. 2009;3:37–49.
29.Thompson, WW, Shay, DK, Weintraub, E, et alMortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186.
32.Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615.
33.Ginocchio, CC, Lotlikar, M, Falk, L, et alClinical performance of the 3M Rapid Detection Flu A+B Test compared to R-mix culture, DFA, and BinaxNow Influenza A+B Test. J Clin Virol. 2009;45:146–149.
34.Ghebremedhin, B, Engelmann, I, Konig, W, et alComparison of the performance of the rapid antigen detection actin Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol. 2009;58:365–370.
35.Grondhal, B, Puppe, W, Weigl, J, et alComparison of the BD Directigin Flu A+B kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and respiratory synctial virus. Clin Microbiol Infect. 2005;11:848–850.
36.Hurt, AC, Alexander, R, Hibbert, J, et alPerformance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39:132–135.
37.Cazacu, AC, Demmler, GJ, Neuman, MA, et alComparison of a new lateral-flow chromatographic membrane immunoassay to viral culture for rapid detection and differentiation of Influenza A and B viruses in respiratory specimens. J Clin Microbiol. 2004;42:3661–3664.
38.Pabbaraju, K, Tokaryk, KL, Wong, S, et alComparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J Clin Microbiol. 2008;46:3056–3062.
39.Kowalski, RP, Karenchak, LM, Romanowski, EG, et alEvaluation of the shell vial technique for detection of ocular adenovirus. Ophthalmology. 1999;106:1324–1327.
41.Gall, A, Hoffmann, B, Harder, T, et alRapid haemagglutinin subtyping and pathotyping of avian influenza viruses by a DNA microarray. J Virol Methods. 2009;160:200–205.
42.Townsend, MB, Dawson, ED, Mehlmann, M, et alExperimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J Clin Microbiol. 2006;44:2863–2871.
43.Huang, Y, Tang, H, Duffy, S, et alMultiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol. 2009;470:390–396.
45.Gubareva, L, Okomo-Adhiambo, M, Deyde, V, et alUpdate: drug susceptibility of swine-origin influenza A (H1N1) viruses. MMWR Morb Mortal Wkly Rep. 2009;58:433–435.
48.Khan, AS, Sage, MJ.Biological and chemical terrorism: strategic plan for preparedness and response—recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep. 2000;49:1–14.
49.McBride, MT, Masquelier, D, Hindson, BJ, et alAutonomous detection of aerosolized Bacillus anthracis and Yersinia pestis. Anal Chem. 2003;75:5293–5299.
50.Hindson, BJ, Makarewicz, AJ, Setlur, US, et alAPDS: the autonomous pathogen detection system. Biosens Bioelectron. 2005;20:1925–1931.
51.Regan, JF, Makarewicz, AJ, Hindson, BJ, et alEnvironmental monitoring for biological threat agents using the autonomous pathogen detection system with multiplexed polymerase chain reaction. Anal Chem. 2008;80:7422–7429.
52.Jernigan, DB, Raghunathan, PL, Bell, BP, et alInvestigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019–1028.
53.Baillie, LWJ.Past, imminent and future human medical countermeasures for anthrax. J Appl Microbiol. 2006;101:594–606.
54.Shepard, CW, Soriano-Gabarro, M, Zell, ER, et alAntimicrobial post exposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis. 2002;8:1124–1132.
55.Kost, GJ.Newdemics, public health, small-world networks, and point-of-care testing. Point of Care. 2006;5:138–144.
56.Jamison, DT, Breman, JG, Measham, AR, et alPriorities in Health. Washington, DC: The World Bank; 2006:216.
57.Louie, RF, Sumner, SL, Belcher, S, et alThermal stress and point-of-care testing performance: suitability of glucose test strips and blood gas cartridges for disaster response. Disaster Med Public Health Preparedness. 2009;3:13–17.
59.Bisoffi, M, Hjelle, B, Brown, DC, et alDetection of viral bioagents using a shear horizontal surface acoustic wave biosensor. Biosens Bioelectron. 2008;23:1397–1403.
60.Zhu, H, Stybayeva, G, Macal, M, et alA microdevice for multiplexed detection of T-cell-secreted cytokines. Lab Chip. 2008;8:2197–2205.
61.Kost, GJ, Korte, B, Beyette, F, et alThe NIBIB Point of Care Technologies Research Network center themes and opportunities for exploratory POC projects. Point of Care. 2008;7:41.
62.Lam, C, Waldhorn, R, Toner, E, et alThe prospect of using alternative medical care facilities in an influenza pandemic. Biosecur Bioterror. 2006;4:384–390.